Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Analytical Chemistry >  Analysis reagents >  Ion chromatography reagents >  Silybin

Silybin

Basic information Safety Supplier Related

Silybin Basic information

Product Name:
Silybin
Synonyms:
  • Silybin A,B (Mixture)
  • Silybin (Mixture of Diastereomers)
  • 4H-1-Benzopyran-4-one, 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-
  • (2R,3R)-3,5,7-Trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)chroman-4-one
  • (2R,3R)-3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-o ne
CAS:
802918-57-6
MF:
C25H22O10
MW:
482.44
EINECS:
806-403-5
Product Categories:
  • Aromatics
  • Chiral Reagents
  • Intermediates & Fine Chemicals
  • Isotope Labelled Compounds
  • Pharmaceuticals
Mol File:
802918-57-6.mol
More
Less

Silybin Chemical Properties

Melting point:
152-153°C
Boiling point:
793.0±60.0 °C(Predicted)
Density 
1.527±0.06 g/cm3(Predicted)
storage temp. 
Refrigerator
solubility 
Acetone (Sparingly, Sonicated, Heated), DMSO (Slightly), Methanol (Slightly, Heated)
pka
7.39±0.60(Predicted)
form 
Solid
color 
Pale Yellow to Beige
InChIKey
SEBFKMXJBCUCAI-DBMPWETRSA-N
SMILES
[C@H]1(C2=CC=C3OC(CO)C(C4=CC=C(O)C(OC)=C4)OC3=C2)OC2=CC(O)=CC(O)=C2C(=O)[C@@H]1O
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-37/39
WGK Germany 
3
RTECS 
DJ2981770
More
Less

Silybin Usage And Synthesis

Chemical Properties

Beige Solid

Uses

Reference standard in the analysis of herbal medicinal products.

Uses

Hepatoprotectant. In nature, the flavonolignan Silybin occurs as a mixture of two diastereomers, Silybin A and Silybin B.

General Description

Produced and qualified by HWI pharma services GmbH.
Exact content by quantitative NMR can be found on the certificate.

in vivo

Silybin (50, 100?mg/kg/day; given intragastrically for the last 4 weeks) significantly lowers both serum and hepatic lipid accumulation[2].

Animal Model:Male C57BL/6J mice (6-8 weeks old) with nonalcoholic fatty liver disease (NAFLD)[2]
Dosage:50, 100?mg/kg
Administration:Given intragastrically; daily; for the last 4 weeks
Result:Significantly lowered both serum and hepatic lipid accumulation.

SilybinSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Hubei kangen Pharmaceutical Chemical Co., Ltd
Tel
153-15337215803 15337215803
Email
3357312443@qq.com
Shanghai Haozhixiang Biotechnology Co., Ltd
Tel
526763801 13301653310
Email
526763801@qq.com